Skip to main content

Table 1 Distribution of the clinical features of patients with oral BSCC, W/MSCC and PDSCC

From: Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?

Clinical features

No. of cases (%)

 

BSCC

PDSCC

W/MSCC

p value*

Sex

       

 Male

15

88.2

25

96.1

26

92.9

NA

 Female

2

11.8

1

3.9

2

7.1

Ethnic group

       

 White

15

88.2

22

84.6

24

85.7

NA

 Non-White

2

11.8

4

15.4

4

14.3

Age, y

       

 ≤ 59

7

41.2

15

57.7

16

57.1

.504

 > 59

10

58.8

11

42.3

12

42.9

Tobacco#

       

 Yes

12

85.7

22

91.7

22

88.0

NA

 No

2

14.3

2

8.3

3

12.0

Alcohol#

       

 Yes

10

76.9

21

87.5

22

88.0

NA

 No

3

23.1

3

12.5

3

12.0

Clinical T classification

       

 T1 - 2

5

29.4

6

23.1

9

32.1

.754

 T3 - 4

12

70.6

20

76.9

19

67.9

Clinical N classification

       

 N0

5

29.4

8

30.8

9

32.1

.981

 N1 - 2 - 3

12

70.6

18

69.2

19

67.9

Tumor site

       

 Tongue

3

17.7

5

19.3

7

25.0

NA

 Floor of mouth

10

58.8

9

34.6

8

28.6

 Retromolar/gingiva

4

23.5

12

46.1

13

46.4

Neck dissection

       

 Without

0

0.0

0

0.0

1

3.6

NA

 Ipsilateral

9

53.0

19

73.0

22

78.6

 Bilateral

8

47.0

7

27.0

5

17.8

Radiotherapy

       

 Yes

15

88.2

22

84.6

18

64.3

NA

 No

2

11.8

4

15.4

10

35.7

Chemotherapy

       

 Yes

3

17.7

7

26.9

5

17.9

NA

 No

14

82.3

19

73.1

23

82.1

Total

17

100

26

100

28

100

 
  1. Abbreviations: BSCC basaloid squamous cell carcinoma, PDSCC poorly differentiated squamous cell carcinoma, W/MSCC well to moderately differentiated squamous cell carcinoma, NAnot applicable.
  2. *Analysis by chi-square test at 5% significance level.
  3. #Excluding patients with lost records.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us